JohnTill
Posted - 1 day ago
$IMAB Another lesson why you never fall in love with a stock. Story changed dramatically and they raided the assets to benefit the China holders. Thanking my lucky stars for avoiding the disaster. Some powerful players still involved so a run down the road will not surprise but how low do they take it first.
forfun88
Posted - 1 day ago
$IMAB is @JohnTill still in this lol. I remember when he was pumping in the teens. This is still a scam company. Gave away all near term assets to the China entity that is now ran by the original founder of Imab! No earnings calls either. No respect for any of you sheep
ieatbaguette
Posted - 1 day ago
$IMAB wow never thought this would hit under a dollar. Kinda scared this may continue falling not sure when to enter so I guess I should start now
Stocksman45
Posted - 2 days ago
@FF355 That’s true and could give $IMAB a much larger cash runway, depending on TJs worth in the market. Current prices are due to RFK spooking the biotech markets. He might actually make FDA approval red tape reduced, which would be good for biotechs not bad.
Stocksman45
Posted - 2 days ago
$IMAB Most biotechs down. RFK. Overblown reaction. If anything he could speed up FDA approval and make it more efficient. “Biotech had its worst weekly performance since 2020 last week, driven by the post-election rally fizzling and fears surrounding RFK Jr.'s potential impact on the FDA.”
iui33
Posted - 2 days ago
$IMAB even tho it looks good on paper, stock price is telling another story. neutral here
serfi
Posted - 2 days ago
$IMAB what a beautiful short
iui33
Posted - 3 days ago
$IMAB kept the rights to its entire portfolio outside of China, including eftansomatropin alfa, a long-acting recombinant human growth hormone that scored a phase 3 win last year in children with growth hormone deficiency.
iui33
Posted - 6 days ago
$IMAB 7x from here
FF355
Posted - 6 days ago
$IMAB TJ bio ‘s pipeline . This company alone could be worth couple billions which I-mab owns 15%
FF355
Posted - 1 week ago
$IMAB I-mab ownership in TJ bio is 15%. This alone is larger than the market cap of the company
Wannanchagri
Posted - 1 week ago
$IMAB $MNOV 🚨💥🚀🔥 PR is incoming. $BOLT.CN $.31 (+19.23%) average volume increased ~100%. I'm going to add on Monday if it's still this low. Latest News 🚀🤑 Market cap at $5.7M; Whiting’s influence may drive upward movement if new partnerships or exploration progress 1️⃣ Bolt Metals ($BOLT.CN) advances with two key updates: Ben Whiting joins as Technical Advisor, and a C$544,500 private placement closed 💸. 2️⃣ Funding: The placement includes shares and warrants, exercisable at C$0.75 for two years, with proceeds for exploration, working capital, and copper project growth ⚒️
iui33
Posted - 1 week ago
$IMAB just told us it got 15% from a 237m deal. thats half of their current valuation
Stocksman45
Posted - 1 week ago
$IMAB This statement in the earnings reports indicates IMAB now owns 15% (up from 9%) of TJ Bio, the remaining Chinese entity.
“I-Mab's ownership in TJ Bio post-settlement of the repurchase obligations is approximately 15%”
DonCorleone77
Posted - 1 week ago
$IMAB I-Mab reports Q3 EPS (25c) vs. (39c) last year Reports no revenue in Q3 vs. $315K last year. The company expects its existing cash and cash related balances to be sufficient to fund its current operating plan into 2027. "I-Mab is making excellent progress in advancing the development of our pipeline projects, supported by our strong cash balance, streamlined operating model, and a focused in-licensing strategy," said Sean Fu, CEO. "In addition, Phase 1 data presented this year for uliledlimab, givastomig, and ragistomig at four international medical conferences highlight the strength of our early data sets for each program. These results have provided us with a strong foundation for advancing each molecule into expanded clinical trials, including Phase 2 studies, in the next year."
iui33
Posted - 1 week ago
$IMAB Hangzhou’s TJ Biopharma sold the China rights for its CD73-targeted antibody to Sanofi in a deal worth up to $237 million. 9% belongs ti IMAB also IMAB keeps the rights for the rest of the world. This drug alone worths 500m. Mcap at the moment 80m + 200m at hand. Its a def buy here.
iui33
Posted - 1 week ago
$IMAB givastomig optimum dosage of 8-12 mg/kg. High tumor targeting also. Long story short medium dosage high results. Feature looks bright. Fingers crossed
larsson13
Posted - 2 weeks ago
$IMAB 46k premarket trades so far, weird.
iui33
Posted - 2 weeks ago
$IMAB the low is in
iui33
Posted - 10/30/24
$IMAB for the treatment of cancer, today announced the presentation of a poster highlighting Phase 1 optimized dose estimation data for givastomig monotherapy (TJ033721/ABL111), a novel first-in-class Claudin18.2 (CLDN18.2) and 4-1BB bispecific antibody, at SITC 2024. They are in a harry!!!
iui33
Posted - 10/29/24
$IMAB https://www.benzinga.com/pressreleases/24/09/n40789214/i-mab-presents-positive-uliledlimab-pharmacokinetics-data-at-2024-world-conference-on-lung-cancer These data, plus a previously presented favorable safety profile and clinical efficacy, fortify our view that uliledlimab has the potential to meaningfully improve the care of patients with mNSCLC
iui33
Posted - 10/29/24
$IMAB while they have 207M$ at hand. So you get 2.1 dollars for 1 dollar...
Vsrtrade
Posted - 10/25/24
$IMAB the price action is different, long term hold. I just keep adding more
FF355
Posted - 1 month ago
$IMAB the run up starts here. Mark my word
RollingDollars
Posted - 1 month ago
$IMAB
Tika1
Posted - 1 month ago
$IMAB After dealing with its Chinese counterpart, is it possible that $SNY is looking to buy or do a deal with $IMAB? Has something been leaked?
SecondChances
Posted - 1 month ago
$IMAB news 2 weeks back put a valuation of $12. Long way to go.
larsson13
Posted - 1 month ago
$IMAB where does the vol come from with no news, think this happened 2 weeks ago as well?